Adeno-associated viral vector gene expression in the adult rat spinal cord following remote vector delivery

Neurobiology of Disease

Volumn 14, Issue 3, 2003, Pages 535-541

  Boulis, Nicholas M ^a,b   Noordmans, Aaron J ^b   Song, Debbie K ^b   Imperiale, Michael J ^b,c   Rubin, Adam ^b   Leone, Paola ^d   During, Matthew ^e   Feldman, Eva L ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^e UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Adeno associated virus; Sciatic nerve; Spinal cord

Indexed keywords

BETA GALACTOSIDASE; GREEN FLUORESCENT PROTEIN; PARVOVIRUS VECTOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; REPORTER GENE; SCIATIC NERVE; SPINAL CORD; SPINAL CORD NERVE CELL; SPINAL GANGLION; VIRAL GENE DELIVERY SYSTEM; VIRUS EXPRESSION;

EID: 0346218252     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2003.08.025     Document Type: Article

References (28)

1. Boulis N., Bhatia V., et al. Adenoviral nerve growth factor and β-galactosidase transfer to spinal cord a behavioral and histological analysis . J. Neurosurg. 90:(1 Suppl):1999;99-108.
2. Boulis N., Turner D., et al. Neuronal survival following remote adenovirus vector delivery. J. Neurosurg. 96:(2 Suppl):2000;212-219.
3. Boulis N., Turner D.E., et al. Characterization of adenoviral gene expession in spinal cord after remote vector delivery. Neurosurgery. 45:1999;131-137.
4. Bueler H. Adeno-associated viral vectors for gene transfer and gene therapy. Biol. Chem. 380:1999;613-622.
5. Chamberlin N., Du B., et al. Recombinant adeno-associated virus vector use for transgene expression and anterograde tract tracing in the CNS . Brain Res. 793:(1-2):1998;169-175.
6. Chesselet, M.-F., 1990. In situ hybridization histology. CRC Press, Inc., Boca Raton, Ann Arbor, Boston, pp. 199-200.
7. Dittrich R.H., Thoenen H., et al. Cileary neurotrophic factor pharmacokinetics and acute phase response in rat . Ann. Neurol. 35:1994;151-163.
8. Durham H., Lochmuller H., et al. Toxicity of replication-defective adenoviral recombinants in dissociated culture of nervous tissue. Exp. Neurol. 140:1996;14-20.
9. Dyer M., Herrling P.L. Progress and potential for gene-based medicines. Mol. Ther. 1:2000;213-224.
10. Feldman E., Sullivan K., et al. Insulin-like growth factors regulate neuronal differentiation and survival. Neurobiol. Dis. 4:1997;201-214.
11. Fink D.J., Ramakrishnan R., et al. Advances in the development of herpes simplex virus-based gene transfer vectors for the nervous system. Clin. Neurosci. 3:1996;284-291.
12. Giehl K.M., Schacht C.M., et al. GDNF is a trophic factor for adult rat corticospinal neurons and promotes their long-term survival after axotomy in vivo. Eur. J. Neurosci. 9:1997;2479-2488.
13. Glatzel M., Flechsig E., et al. Adenoviral and adeno-associated viral transfer of genes to the peripheral nervous system. Proc. Natl. Acad. Sci. USA. 97:2000;442-447.
14. Kaplitt M., During M. Transfer and expression of potentially therapeutic genes into the mammalian central nervous system in vivo using adeno-associated viral vectors. Kaplitt M., et al. Viral Vectors. 1995;193-210 Academic Press, San Diego.
15. Kaplitt M., Leone P., et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 8:1994;148-154.
16. Kaspar B., Erickson D., et al. Targeted retrograde gene delivery for neuronal protection. Mol. Ther. 5:2002;50-56.
17. Klein R., Hamby M., et al. Dose and promoter effects of adeno-associated viral vector for green fluorescent protein expression in the rat brain. Exp. Neurol. 176:2002;66-74.
18. Lewin G.R. Neurotrophic factors and pain. Semin. Neurosci. 7:1995;227-232.
19. Loeb J., Cordier W., et al. Enhanced expression of transgenes from adeno-associated virus vectors with the woodchuck hepatitis virus posttranscriptional regulatory element implications for gene therapy. Hum. Gene Ther. 10:1999;2295-2305.
20. Mastakov M., Baer K., et al. Combined injection of rAAV with mannitol enhances gene expression in the rat brain. Mol. Ther. 3:2001;225-232.
21. Murakami T., Nagano I., et al. Impaired retrograde axonal transport of adenovirus-mediated E. coli LacZ gene in mice carrying mutant SOD1 gene. Neurosci. Lett. 308:2001;149-152.
22. Peel A., Zolotukhin S., et al. Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters. Gene Ther. 4:1997;16-24.
23. Song, D., Boulis, N., et al., 2001. Remote adeno-associated viral gene delivery to the spinal cord and dorsal root ganglion in streptozotocin-treated mice. Soc. Neurosci. Abstr. 27, 361-365.
24. Xiao X., Li J., et al. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70:1996;8098-8108.
25. Xiao X., Li J., et al. Gene transfer by adeno-asociated virus vectors into the central nervous system. Exp. Neurol. 144:1997;113-124.
26. Xiao X., McCown T., et al. Adeno-associated virus (AAV) vector antisense gene transfer in vivo decreases GABA (A) alpha 1 containing receptors and increases inferior collicular seizure sensitivity. Brain Res. 756:1997;76-83.
27. Yamashita S., Mita S., et al. Bcl-2 expression by retrograde transport of adenoviral vectors with Cre-loxP recombination system in motor neurons of mutant SOD1 transgenic mice. Gene Ther. 8:2001;977-986.
28. Yang Y., Su Q., et al. Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs. J. Virol. 70:1996;7209-7212.